The impact of the COVID-19 pandemic on gestational carriers

Reproductive medicine has been significantly impacted by the coronavirus (COVID-19) pandemic, and this includes the gestational carrier (GC) process. The objectives of this commentary are to evaluate the impact of COVID-19 on the GC process, as well to communicate Shady Grove Fertility’s considerati...

Full description

Saved in:
Bibliographic Details
Published in:Journal of assisted reproduction and genetics 2022-10, Vol.39 (10), p.2365-2372
Main Authors: Romanello, Jennifer P., Sun, Bei, Hill, Micah J., Singer, Tomer, O’Brien, Jeanne E.
Format: Article
Language:English
Subjects:
Coronaviruses
COVID-19
COVID-19 - epidemiology
Female
Fertility
Gynecology
Health Personnel
Human Genetics
Humans
Infant, Newborn
Medicine
Medicine & Public Health
Morbidity
Neonates
Pandemics
Pregnancy
Reproductive health
Reproductive Medicine
Reproductive Physiology and Disease
Reproductive Techniques, Assisted
Reproductive technologies
Surrogate Mothers
Vaccination
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Reproductive medicine has been significantly impacted by the coronavirus (COVID-19) pandemic, and this includes the gestational carrier (GC) process. The objectives of this commentary are to evaluate the impact of COVID-19 on the GC process, as well to communicate Shady Grove Fertility’s considerations of and response to COVID-19 on the GC process to the larger assisted reproductive technology (ART) community. We also gathered conclusions drawn from available data on the impact of COVID-19 infection on maternal and neonatal morbidity and mortality as well as on counseling patients on vaccination. We compiled proposals to mitigate risk and to maximize safe evaluation and treatment for GCs during the ongoing pandemic. Over 2 years after the onset of the pandemic, the multiple resurgences of cases in the USA have necessitated nimble strategies to provide ongoing and safe reproductive care and have posed unique challenges to the GC process. With the prospect of the virus continuing to spread globally well into the future, as healthcare professionals of the ART community, we will need to ensure effective collaboration and communication as we provide care during the ongoing pandemic.
ISSN:1058-0468
1573-7330
1573-7330
DOI:10.1007/s10815-022-02622-w